Metronidazole Injection Shortage: FDA Update
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Metronidazole Injection is currently listed in shortage by the FDA, an anti-infective medication, with one manufacturer reporting availability as of the latest update.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Metronidazole.
Metronidazole Injection Shortage
As a professional health news writer for Areazine, we aim to provide empathetic and informative coverage of drug shortages that may affect patients relying on these medications.
What's in Shortage
The generic drug name is Metronidazole Injection, with the brand name METRONIDAZOLE. It is available in injection dosage form and is currently in shortage status. It falls under the therapeutic category of Anti-Infective. The shortage was first posted on 01/13/2022 and last updated on 04/01/2026.
Which Manufacturers Are Affected
Baxter Healthcare is the manufacturer listed, and their product is available. Their specific presentation is Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48). For inquiries, their contact information is 888-229-0001.
Why There's a Shortage
No specific reason was provided for the shortage.
What Patients Should Do
Patients experiencing issues with obtaining this medication should speak with their pharmacist or healthcare provider to check availability. They can also inquire about general options and contact the manufacturer directly if needed. Please remember that patients should always consult their healthcare provider for personalized advice and not make changes without professional guidance.
Source
This information is sourced from the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,390 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.